Archive for

Antibiotic Resistance: An Emerging Threat

One of my most vivid recollections from residency training is that of a patient we had in the ICU who was gravely ill from an infection. We treated her infection as we usually do in these situations – supportive care and antibiotics. What was so unusual about her case that I still remember it to … Continue reading


11 Blockbuster Drugs for 2015 – What Are They and Who Is Making Them?

I’ve been reading a lot about this Thomson Reuters analysis about this year’s predicted blockbuster drugs (i.e., drugs predicted to make over $1 billion in US dollars). Their track record is pretty solid given they predicted big things for Gilead Sciences’ oral drug Sovaldi (sofosbuvir)/Harvoni (sofosbuvir plus ledipasvir) for hepatitis C viral infection, GlaxoSmithKline/Theravance’s Anoro Ellipta (umeclidinium … Continue reading